Joe Harpaz Joins Modernizing Medicine as President and Chief Operating Officer
Thomson Reuters Corp Ordinary Shares (TRI)
Last thomson reuters corp ordinary shares earnings: 2/25 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thomsonreuters.com
Company Research
Source: Business Wire
Seasoned Business and Operations Leader to Help Scale Specialty-Specific Health IT Company BOCA RATON, Fla.--(BUSINESS WIRE)-- Specialty-specific healthcare information technology leader Modernizing Medicine, Inc. has appointed Mr. Joe Harpaz as the company’s president and chief operating officer (COO). Mr. Harpaz will lead all direct customer-facing activities, with an emphasis on scaling the business and supporting its customers as they navigate the shifting healthcare landscape. This press release features multimedia. View the full release here:https://www.businesswire.com/news/home/20180716005304/en/ Joe Harpaz, President and Chief Operating Officer of Modernizing Medicine (Photo: Business Wire) Mr. Harpaz brings over two decades of experience in technology, business and leadership to Modernizing Medicine’s executive team. He joins the company after a very successful leadership career at global informat
Show less
Read more
Impact Snapshot
Event Time:
TRI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TRI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TRI alerts
High impacting Thomson Reuters Corp Ordinary Shares news events
Weekly update
A roundup of the hottest topics
TRI
News
- Thomson Reuters announces expanded vision to provide GenAI assistant for every professional it servesPR Newswire
- Thomson Reuters announces expanded vision to provide GenAI assistant for every professional it servesPR Newswire
- Thomson Reuters First-Quarter 2024 Earnings Announcement and Webcast Scheduled for May 2, 2024PR Newswire
- Thomson Reuters Co. (NYSE: TRI) had its price target raised by analysts at TD Securities from $210.00 to $225.00. They now have a "hold" rating on the stock.MarketBeat
- Thomson Reuters Co. (NYSE: TRI) had its price target raised by analysts at CIBC from $146.00 to $152.00. They now have a "neutral" rating on the stock.MarketBeat
TRI
Earnings
- 2/8/24 - Beat
TRI
Sec Filings
- 3/13/24 - Form 144
- 3/7/24 - Form 6-K
- 3/7/24 - Form IRANNOTICE
- TRI's page on the SEC website